IL79595A0 - Anticonvulsant compositions and method - Google Patents

Anticonvulsant compositions and method

Info

Publication number
IL79595A0
IL79595A0 IL79595A IL7959586A IL79595A0 IL 79595 A0 IL79595 A0 IL 79595A0 IL 79595 A IL79595 A IL 79595A IL 7959586 A IL7959586 A IL 7959586A IL 79595 A0 IL79595 A0 IL 79595A0
Authority
IL
Israel
Prior art keywords
anticonvulsant
compositions
anticonvulsant compositions
Prior art date
Application number
IL79595A
Other languages
English (en)
Original Assignee
Univ New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York filed Critical Univ New York
Publication of IL79595A0 publication Critical patent/IL79595A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL79595A 1985-08-16 1986-08-04 Anticonvulsant compositions and method IL79595A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/766,838 US4694010A (en) 1985-08-16 1985-08-16 Anticonvulsant compositions and method

Publications (1)

Publication Number Publication Date
IL79595A0 true IL79595A0 (en) 1986-11-30

Family

ID=25077679

Family Applications (1)

Application Number Title Priority Date Filing Date
IL79595A IL79595A0 (en) 1985-08-16 1986-08-04 Anticonvulsant compositions and method

Country Status (8)

Country Link
US (1) US4694010A (da)
EP (1) EP0233932A4 (da)
JP (1) JPS63500598A (da)
AU (1) AU579028B2 (da)
DK (1) DK178687A (da)
IL (1) IL79595A0 (da)
WO (1) WO1987001036A1 (da)
ZA (1) ZA866194B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4788055A (en) * 1985-12-09 1988-11-29 Ciba-Geigy Corporation Resinate sustained release dextromethorphan composition
US4806543A (en) * 1986-11-25 1989-02-21 Board Of Trustees Of The Leland Stanford Junior University Method and compositions for reducing neurotoxic injury
WO1989005642A1 (en) * 1987-12-22 1989-06-29 Ferkany John W Dextrorphan potentiator for anticonvulsant composition and method
US4906638A (en) * 1987-12-22 1990-03-06 Nova Pharmaceutical Corporation Dextromethorphan potentiator for anticonvulsant composition and method
US5234929A (en) * 1992-07-20 1993-08-10 William Chelen Method of treating motion sickness with anticonvulsants and antitussive agents
DE69733081T2 (de) * 1996-08-23 2006-05-11 Endo Pharmaceuticals Inc. (n.d.Ges.d. Staates Delaware) Antikonvulsive mitteln enthaltende zubereitung zur behandlung von neuropathischen schmerzen
AU8668598A (en) 1997-08-20 1999-03-08 University Of Oklahoma, The Gaba analogs to prevent and treat gastrointestinal damage
AU2002301362B8 (en) * 1997-09-08 2006-05-04 Warner-Lambert Company Analgesic compositions comprising anti-epileptic compounds and methods of using same
WO1999012537A1 (en) 1997-09-08 1999-03-18 Warner-Lambert Company Analgesic compositions comprising anti-epileptic compounds and methods of using same
US6451857B1 (en) 1999-03-10 2002-09-17 Warner-Lambert Company Analgesic compositions comprising anti-epileptic compounds and methods of using same
US20040002543A1 (en) * 2001-02-16 2004-01-01 Leslie Magnus Compositions comprising GABA analogs and a decongestant to relieve sinus headache pain
EP3632916B1 (en) 2007-05-01 2022-06-08 Concert Pharmaceuticals Inc. Morphinan compounds
MX370608B (es) * 2007-05-01 2019-12-18 Concert Pharmaceuticals Inc Compuestos de morfinano.
DK2792662T3 (da) 2007-05-01 2016-07-25 Concert Pharmaceuticals Inc Morphinanforbindelser
JP5730769B2 (ja) 2008-09-19 2015-06-10 コンサート ファーマシューティカルズ インコーポレイテッド モルヒナン化合物
EP3825307B1 (en) 2016-07-04 2022-08-03 Avanir Pharmaceuticals, Inc. Methods for the synthesis of deuterated dextromethorphan
CN108853502B (zh) * 2017-05-09 2024-06-14 浙江大学 治疗抑郁症的方法和药物组合物
CN108853510B (zh) * 2017-05-09 2022-05-20 浙江大学 Nmdar抑制剂和t型钙离子通道抑制剂的组合对抑郁症的治疗和药物
EP3636281B1 (en) 2017-05-09 2023-11-01 Zhejiang University Method for treating depression, and pharmaceutical composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5227M (da) * 1966-03-18 1967-08-14
US4316888A (en) * 1980-04-15 1982-02-23 Nelson Research & Development Co. Method and composition of reducing pain

Also Published As

Publication number Publication date
AU6283786A (en) 1987-03-10
EP0233932A1 (en) 1987-09-02
JPS63500598A (ja) 1988-03-03
AU579028B2 (en) 1988-11-10
ZA866194B (en) 1987-04-29
US4694010A (en) 1987-09-15
EP0233932A4 (en) 1988-04-26
DK178687D0 (da) 1987-04-08
DK178687A (da) 1987-04-08
WO1987001036A1 (en) 1987-02-26

Similar Documents

Publication Publication Date Title
GB2177108B (en) Shampoo compositions and method
EP0183556A3 (en) Immunopotentiating agents and method
ZA866194B (en) Anticonvulsant compositions and method
ZA859339B (en) Processes and compositions
IL75325A (en) Immunostimulating agents containing certain substituted quinolone-carboxylic acids and their preparation
ZA875601B (en) Shampoo method and composition
GR860797B (en) Compounds and method
ZA866428B (en) Anticonvulsant method and formulations
GB2271665B (en) Thermoelectrochemical system and method
ZA857124B (en) 13-halomilbemycins and 13-hydroxymilbemycins
GR860078B (en) Spiro - dioxolanes - dithiolanes and oxothiolanes
EP0214102A3 (en) 5-aralkyl-substituted 2h-benzotriazoles and stabilized compositions
GB2178768B (en) Hair softening method and compositions
ZA867244B (en) Nematicidal compositions and method
EP0230052A3 (en) Immunoamplifiers and related compositions
GB8520640D0 (en) Fastening method
EP0192481A3 (en) Transportation and construction method
EP0273571A3 (en) Separating-agents composition and method using same
ZA864886B (en) Antibiotic method and formulations
DE3665866D1 (en) Method for silalactone preparation and use
PH20880A (en) Substituted benzoxepines and isochromanes
BG47569A1 (en) 1- thiocarbamoylmethylpyrolidene- 2- tion and method for its preparation
BG48273A1 (en) Polymerisationable oligoimide and method for its preparation
GR862408B (en) Method for preparing alkenylazoles and their application
GB8406038D0 (en) Composition and method